Aleutian Mink Disease Virus: Parvovirus Reference

Overview and Taxonomy of Aleutian Mink Disease Virus: Parvovirus Reference

Aleutian mink disease virus (AMDV) represents a paradigmatic example of a small, non‐enveloped, single-stranded DNA virus that falls under the family Parvoviridae. Within this diverse family, AMDV is classified in the genus Amdoparvovirus, a group that diverges significantly from other parvoviruses in its genomic organization, replication strategy, and host interactions. As a pathogen of profound economic and animal health significance, particularly within the mink farming industry, AMDV exhibits unique molecular and structural characteristics that make it a subject of deep investigation by veterinary researchers worldwide [2, 10].

Taxonomic Classification and Molecular Features

Taxonomically, AMDV occupies a specialized niche in the Parvoviridae family. Members of this family are generally characterized by their small genomes, typically around 4–6 kilobases, and a capsid structure that features icosahedral symmetry composed of 60 subunits, or viral proteins (VPs), which interact via two-, three-, and five-fold symmetry axes [2]. Detailed cryo-electron microscopy studies have revealed that despite low amino acid sequence similarity with other parvoviruses, AMDV retains the classical features of the parvovirus capsid while exhibiting distinct variations in its surface loops. These variances may underlie differences in host receptor binding and immune evasion strategies [2]. In contrast to many of its parvoviral relatives, AMDV has an intricate genomic expression pattern that utilizes alternative splicing to produce multiple transcripts. Among these, the large nonstructural protein NS1 is central to replication, whereas the smaller nonstructural proteins NS2 and NS3, whose expression has recently been confirmed during infection, are critical for viral replication and pathogenesis [5].

The genomic variability of AMDV is remarkable, with studies reporting extensive genetic divergence among isolates from different geographical regions and host populations [1, 6]. Comparative analyses of partial regions such as VP2, especially the hypervariable domains, reveal genetic distances that can approach 10% nucleotide divergence between strains. This variability is exploited not only to chart the virus’s molecular epidemiology but also to understand its adaptability to both farmed and wild mink and even to native mustelids [1, 3]. Phylogenetic reconstructions based on regions such as NS1 and VP2 have facilitated the identification of several clades, which in turn indicate both local evolution and potential introductions from distinct ancestral sources, a phenomenon intensified by mink farming practices and the frequent intermingling of local and imported animals [6, 8].

Structural Organization and Replication Mechanism

AMDV’s virion structure stands as a defining feature in its classification and functional biology. The capsid, formed from viral proteins arranged in a tightly organized icosahedral assembly, ensures protection of the viral genome while also mediating host cell recognition and entry. High-resolution structural studies not only confirm that AMDV adheres to the classical parvovirus capsid architecture but also highlight unique conformational adaptations in surface loops. These structural adaptations may influence tropism by determining which cellular receptors are engaged during infection and potentially modulate the immune response [2]. Once the virus gains cellular entry, its compact single-stranded genome leverages the host’s replication machinery, beginning with the formation of a replicative intermediate, and employs a rolling-hairpin mechanism shared by other parvoviruses to generate progeny genomes efficiently.

The expression of AMDV’s gene products is intricately controlled. The NS1 protein, a multifunctional enzyme involved in both the initiation and regulation of viral replication, is central to the virus’s life cycle, while experimentally verified expression of NS2 and NS3 further underscores the complexity of AMDV’s replication strategy [5]. Such sophisticated genetic regulation is essential for the virus’s ability to maintain persistent infections in its primary hosts, contributing to the chronic nature of Aleutian disease.

Epidemiological and Evolutionary Insights

The epidemiology of AMDV is tightly interwoven with the dynamics of intensive mink farming, where the virus has spread widely both in captive and free-ranging American mink populations as well as in other susceptible mustelids. Global epidemiological surveillance, endorsed by organizations such as the World Organisation for Animal Health (WOAH) and referenced in sentinel studies, underscores AMDV’s importance as an economically critical pathogen. In mink farming contexts, molecular investigations have detected high seroprevalence rates as well as frequent viral isolation from both clinical and subclinical cases, indicating not only persistent infection but also widespread viral shedding [1, 4]. Such findings have been corroborated by phylogenetic studies that reveal region-specific clusters yet confirm instances of inter-regional virus exchange due to international trade and escape events [6, 8].

AMDV’s evolutionary trajectory is shaped by intense selective pressures inherent to high-density farming and the resultant host immunological interactions. The virus demonstrates a balance between maintaining essential structural determinants for cell entry and allowing sufficient genetic plasticity for antigenic drift, which permits the virus to persist despite immune surveillance. Molecular clock analyses further imply that AMDV’s diversification spans several decades, attesting to long-term endemicity in mink populations around the globe. Moreover, studies have documented recombination events among viral genomes, a sign of co-infection and genetic exchange within hosts, that contribute further to the high intra-farm genetic diversity of the pathogen [8, 9]. Such evolutionary characteristics underscore the dual challenge of managing AMDV as both a persistent infection in mink farms and a pathogen with potential implications for wildlife health.

Broader Context and Zoonotic Considerations

Although the primary pathogenic effects of AMDV are observed in mink where Aleutian disease manifests as chronic plasmacytosis and immune complex-mediated pathology, sporadic findings of AMDV antibodies or viral DNA in humans have raised questions regarding potential zoonotic transmission. Reports of serological evidence in mink farmers, with accompanying vascular diseases reminiscent of the mink pathology, suggest a need for vigilance and further study, particularly in the context of CDC and World Health Organization (WHO) guidelines for monitoring emerging zoonoses [7]. While definitive clinical correlations in humans remain limited, such observations reinforce the importance of considering AMDV within the broader framework of zoonotic pathogens.

Collectively, the taxonomic, structural, and epidemiological profiles of AMDV underscore its status as a key member of the parvovirus family. Its unique mechanisms of replication, high degree of genetic variability, and persistent infection dynamics illustrate the challenges faced in controlling this pathogen in both intensive farming and wildlife settings. The integration of high-resolution structural insights, detailed molecular phylogenetics, and rigorous epidemiological data continues to enhance our understanding of AMDV, a virus that remains at the crossroads of veterinary health and global economic impact.

Molecular Structure, Genomic Organization, and VP2 Hypervariable Region Analysis

Aleutian mink disease virus (AMDV) is a small, non-enveloped, single-stranded DNA virus belonging to the family Parvoviridae, genus Amdoparvovirus. The viral structure, along with its compact genomic organization, plays a pivotal role in viral persistence, host immune evasion, and adaptability. In recent years, advances in molecular and structural virology have provided critical insights into the architecture of AMDV particles, the organization of its genome, and particularly the nature of the hypervariable region in the VP2 capsid protein, which is central to both virulence and immune recognition [2, 5].

Molecular Structure of AMDV

Structural studies of AMDV, notably utilizing cryo-electron microscopy, have revealed that the virus forms an icosahedral capsid constructed from 60 viral proteins. These capsid proteins assemble via interactions noted at the two-, three-, and five-fold symmetry axes, a characteristic common to parvoviruses [2]. The AMDV capsid architecture is not only critical for viral stability but also for receptor binding, host cell entry, and subsequent uncoating. Despite relatively low amino acid conservation among various parvoviruses, AMDV shares the fundamental structural blueprint, which underscores the evolutionary pressures maintaining capsid functionality. The detailed molecular portraits provided by high-resolution imaging techniques have allowed researchers to annotate surface-exposed loops and other structural domains that may interact with host immune factors. The capsid structure serves as the scaffold upon which genetic variability, especially within the hypervariable regions of the capsid protein VP2, exerts significant phenotypic effects in terms of immune evasion and pathogenicity [2].

Genomic Organization of AMDV

The AMDV genome exhibits a compact organization, typical of small DNA viruses, and is arranged into two principal open reading frames (ORFs). The first ORF codes for nonstructural proteins (NS1, NS2, and NS3), which are indispensable for viral replication and regulation of gene expression. These proteins, expressed through mechanisms such as alternative splicing and polyadenylation, orchestrate the virus's replication cycle by engaging in nucleic acid binding, helicase activity, and modulation of host cell responses [5]. The second ORF encodes the structural proteins, primarily VP1 and VP2, where VP2 is the major capsid component and plays a crucial role in determining antigenic properties of the virus. Although VP1 is present in minor quantities, it is believed to contribute to the assembly process and initial entry into host cells.

A key feature of the genomic organization is the location and nature of the hypervariable region within the VP2 gene. This region is characterized by an accumulation of single nucleotide polymorphisms and amino acid substitutions that are often correlated with differences in virulence and host immune responses. Comparative genomic analyses of field isolates have demonstrated significant variability in this region, sometimes accompanied by deletion mutations that may alter the antigenic landscape of the virus [1, 12].

VP2 Hypervariable Region Analysis

The VP2 capsid protein is the major determinant of AMDV antigenicity and is central to immune recognition. The hypervariable region within VP2 has emerged as a hotspot for genetic variation, serving as a molecular “fingerprint” for epidemiological studies. In one study conducted on isolates from northeastern China, sequence alignments of partial VP2 fragments, particularly focusing on the hypervariable region, revealed an 8.3% divergence in nucleotide sequences compared to reference strains [1]. Moreover, amino acid alignments indicated not only multiple genetic variants but also instances of single amino acid deletions, underscoring the high plasticity of this region [1]. The clustered variability in the VP2 hypervariable region appears to be a result of selective pressure exerted by the host immune system, driving the virus to continuously alter surface-exposed epitopes to avoid neutralization.

Phylogenetic reconstructions using VP2 gene sequences have afforded insights into the geographic and evolutionary trajectories of AMDV. For instance, isolates from Chinese mink farms have been shown to form a distinct clade, suggesting both local evolution and possible introductions of diverse strains through mink trade and farming practices [1, 11]. In regions where multiple strains coexist, the hypervariable regions offer a high-resolution mapping tool to track transmission routes and infer historical inter-species transmission events. This is particularly important given the economic significance of AMDV as noted by institutions like the World Organisation for Animal Health (WOAH) and the World Health Organization (WHO), which emphasize the necessity of understanding viral evolution in zoonotic or economically critical pathogens.

Structural implications of the hypervariability within VP2 extend into practical applications. Variability in surface loops often affects the binding of neutralizing antibodies; hence, variants that exhibit changes in these loops can lead to differences in virulence, persistence, or even escape from serological detection methods. For example, while studies have evidenced that the MiCV Cap gene is relatively conserved, the corresponding VP2 gene in AMDV shows marked variability predominantly in virulence-related loci and within its hypervariable region [11]. These findings suggest that selective pressures in the farming environment, including host genetics and immune responses, may preferentially target the VP2 region, fostering rapid evolution and the emergence of strains with differential pathogenic potentials [11, 12].

In addition, the structural variability of the VP2 hypervariable region is integrally linked with the capsid’s overall architecture. The subtle alterations in amino acid composition not only impact antigenicity but may also influence the interactions between VP2 molecules during capsid assembly. This interplay between sequence variability and structural integrity is a delicate balancing act, as the virus must maintain a functional capsid that protects its genomic material while simultaneously evolving to escape host immunity. Contemporary studies employing full genome sequencing have illuminated how sequence differences in the VP2 region correlate with alterations in three-dimensional capsid structure, thereby informing both our understanding of viral pathogenesis and the development of diagnostic reagents [2, 13].

Implications for Epidemiology and Diagnostics

The high degree of variability in the VP2 hypervariable region has significant implications for the molecular epidemiology of AMDV. By focusing on this region, researchers have been able to decipher molecular clusters that correlate with specific geographic locales or farming practices. Such molecular epidemiological studies provide vital information for biosecurity, as tracking the evolution of the VP2 gene can directly inform control strategies on mink farms worldwide. In areas where AMDV poses substantial economic risks, as declared by the Centers for Disease Control and Prevention (CDC) and in guidelines endorsed by the FAO, improvements in molecular diagnostics that target the VP2 gene have the potential to refine surveillance and outbreak management strategies.

Furthermore, the ongoing evolution observed in the hypervariable region necessitates periodic updates and calibration of serological assays, enabling them to capture newly emergent antigenic variants. These assay refinements are critical not only for early disease detection but also for the implementation of effective control measures. Given the profound impact of AMDV on animal health and the fur farming industry, understanding the molecular determinants of virulence embedded within the VP2 gene is paramount. Such insights also facilitate the design of targeted vaccines or immunotherapeutics that could in future be developed to mitigate the economic and animal welfare impacts of the disease [1, 11, 12].

Advanced sequencing technologies have further expanded our understanding by enabling whole-genome comparisons across diverse AMDV isolates, identifying recombination events and pinpointing mutation hotspots within the VP2 coding region [13]. The interplay between genetic drift, selective pressure, and host immune responses enforces a dynamic equilibrium in which the VP2 hypervariable region is constantly shaped by its environment. This ongoing molecular evolution has been consistently documented across various geographic settings, reaffirming the role of the VP2 gene as an essential marker for both epidemiological tracking and understanding the underlying mechanisms of viral persistence and transmission.

By integrating structural biology with genomic analysis, researchers have begun to unravel the complex relationship between the capsid’s construction, its antigenic properties, and the persistent nature of AMDV infection. These findings underscore the necessity for a multifaceted research approach that encompasses molecular virology, structural biology, and epidemiology to fully comprehend and eventually control the spread of AMDV in mink farming systems, an objective that aligns with global disease surveillance and biosecurity recommendations issued by reputable organizations such as the CDC, WHO, WOAH, and FAO [2, 11, 12].

Molecular Pathogenesis and Immune Evasion Mechanisms of Aleutian Mink Disease Virus

Aleutian mink disease virus (AMDV) is an atypical parvovirus characterized by a small, single-stranded DNA genome and a non-enveloped, icosahedral capsid structure. Despite its diminishing pathogenicity in some hosts, the virus maintains a remarkable ability to persist and evade the host immune system, leading to chronic immune-mediated pathology that jeopardizes both animal welfare and mink farming economics. Detailed molecular studies have shed light on the multifaceted mechanisms that underpin the virus’s pathogenesis and its sophisticated immune evasion strategies.

Viral Structure, Genetic Variability, and Host Interactions

The AMDV capsid is formed by 60 viral proteins that organize into a structurally complex assembly, exhibiting remarkable variability in its surface loops, particularly within the VP2 protein. High-resolution cryo-electron microscopy studies have demonstrated that these surface-exposed regions are not only critical for receptor recognition and viral attachment but also serve as primary targets for the host’s neutralizing antibodies [2]. However, the hypervariability in the VP2 gene, often centered on distinct hypervariable segments, results in a dynamic antigenic landscape that continuously challenges the host immune system’s ability to neutralize the virus effectively [1, 11]. This molecular plasticity is a key adaptive strategy, enabling AMDV to escape antibody recognition and establish persistent infections even in immunocompetent hosts.

In addition to structural variability, the viral genome undergoes complex alternative splicing, producing several nonstructural proteins beyond the well-known NS1. Notably, NS2 and NS3 have been experimentally validated as necessary for efficient viral replication, suggesting that these proteins likely play roles in modulating host cell functions to create a more permissive environment for viral replication [5]. This post-transcriptional diversity contributes to an intricate repertoire of viral proteins that can interfere with host immune signaling pathways, thereby facilitating long-term viral persistence.

Mechanisms of Immune Evasion and Chronic Infection

A defining characteristic of AMDV infection is its ability to induce a persistent, chronic immune response that paradoxically exacerbates disease, as seen in conditions such as hypergammaglobulinemia and plasmacytosis. Unlike classic cytopathogenic viral infections, AMDV does not induce rapid cell death; instead, it establishes a state of latent, low-level replication within target tissues such as the spleen and lymph nodes [15, 17]. The virus exploits antibody-dependent enhancement (ADE) mechanisms whereby the formation of virus-antibody complexes facilitates viral entry into macrophages through Fc receptor-mediated internalization. This unique pathway, rather than neutralizing the virus, inadvertently promotes viral dissemination within the host, leading to a vicious cycle of immune activation and tissue injury.

The chronic immune response is further characterized by persistent production of antiviral antibodies that, over time, fail to clear the infection. Instead, these antibodies form circulating immune complexes that deposit in various organs, triggering complement activation and inflammatory cascades. Such immune complex-mediated pathology is central to the clinical manifestation of Aleutian mink disease and is a prime example of how an overactive, or misdirected, immune response can contribute to disease progression. The phenomenon has been well documented in both experimental and naturally infected animals, where elevated levels of serum globulins and prolonged seropositivity correlate with increased tissue damage despite minimal viremia [4, 17].

Studies employing transcriptomic profiling of infected spleen tissues have highlighted the activation of innate immune pathways, including neutrophil degranulation and lipid metabolism alterations [15]. These responses suggest that AMDV infection triggers an early inflammatory response which, rather than being sufficient for virus clearance, may contribute to the dysregulated immune state that favors viral persistence. Additionally, variations in host genetic factors, such as polymorphisms found in immune-regulatory genes like RNF165, have been implicated in differential resistance to infection, further complicating the interplay between viral replication and immune clearance [16].

Interplay Between Viral Evolution and Immune Selection

The rapid evolution and high genetic diversity observed in AMDV strains are partly driven by the selective pressures imposed by the host immune system. Phylogeographic studies have revealed that despite the presence of well-defined clades, significant genetic drift and recombination events are common, particularly within regions encoding the VP2 protein [1, 19]. Such genetic fluidity enables the virus to constantly “shuffle” its antigenic determinants, thereby evading neutralization. The evolution of AMDV is further compounded by cross-species transmission events among mustelids and other carnivores [14, 18], which may provide additional reservoirs for viral diversification and dissemination.

The interplay between viral evolution and the host’s immune response is a dynamic equilibrium. While the host mounts a robust antibody-mediated response, endorsed by surveillance strategies recommended by international authorities such as the CDC and the World Organisation for Animal Health (WOAH), AMDV continually adapts through mutation and recombination to evade detection [19]. Consequently, the selective pressure exerted by both natural immunity and, where applicable, immunological interventions, fosters an environment wherein viruses capable of escaping immune recognition are preferentially maintained. This phenomenon not only results in persistent infections but also underscores the challenges faced by diagnostic and control measures in mink farms.

Molecular Insights into Nonstructural Protein Functions and Immune Modulation

Beyond the capsid proteins, the nonstructural proteins expressed by AMDV, particularly NS1, NS2, and NS3, are believed to interfere with cellular antiviral responses. NS1, a multifunctional protein implicated in viral replication, may also modulate key pathways in the host cell, including those involved in DNA repair and interferon signaling. Concurrently, NS2 and NS3, whose expression has been firmly associated with productive infection [5], are likely to interact with host factors to dampen the antiviral state, thus preventing the activation of apoptosis or other programmed cell death pathways that would be detrimental to the virus. Although further elucidation of these interactions is necessary, current evidence suggests that targeting these nonstructural proteins or their cellular partners could be a viable strategy to disrupt the virus’s ability to maintain its persistent, immune-evasive state.

Collectively, the molecular pathogenesis of AMDV involves a sophisticated convergence of structural adaptations, post-transcriptional modifications, and immune modulation that enables the virus to persist in its host. Through dynamic alterations in its capsid proteins and strategic deployment of nonstructural proteins, AMDV not only evades the host immune response but also leverages that very response to establish a chronic, pathological state. These insights, in conjunction with evolving international guidelines from organizations such as WHO and FAO regarding the control of economically significant viral pathogens, continue to inform and refine both diagnostic and management strategies in the field of veterinary virology [2, 4].

Epidemiology and Phylogenetic Diversity of Aleutian Mink Disease Virus

Aleutian mink disease virus (AMDV) represents a significant pathogen not only for farmed mink but also for free-ranging mustelids and other carnivores that intermittently interface with human activities relating to fur farming. Owing to its broad host range and adaptability to diverse ecological niches, AMDV exhibits a complex epidemiological profile with high phylogenetic diversity. This section details the molecular epidemiology, geographical distribution, mechanisms of viral diversification, and the ongoing dynamics of cross-species transmission, drawing insights from extensive studies [1, 3, 8, 14, 18-21].

Global Distribution and Host Range

AMDV has been documented worldwide, with endemic circulation in mink farms in North America, Europe, and Asia. In northeast China, molecular epidemiological investigations based on the VP2 gene hypervariable region demonstrated the co-circulation of local and imported strains, with a surprisingly high seroprevalence in farmed mink [1]. Similarly, studies in Europe have revealed a high prevalence in both farmed mink and wild mustelids. For instance, research in northeastern Poland indicated that free-ranging American mink and native mustelids such as polecats, weasels, and stone martens harbor the virus, with prevalent infection rates often exceeding 40%, underscoring the significance of the wildlife–farmed interface in sustaining endemic viral circulation [3, 18]. Reports from Spain further highlight that AMDV outbreaks in mink farms have been driven by local reservoirs with distinct phylogenetic signatures, while sporadic introductions through international trade have also been documented [20].

Phylogenetic Clades and Genetic Diversity

Phylogenetic analyses have consistently demonstrated that AMDV exhibits remarkable genetic heterogeneity. Studies utilizing partial sequences, particularly from the VP2 and NS1 genes, have categorized AMDV strains into several distinct clades. For example, the comparative analysis of Chinese isolates with reference strains revealed clustering into three major clades, one of which was specific to the Chinese region [1]. Similarly, whole-genome studies conducted in Finland have identified multiple introduction events with evidence of frequent recombination and inter-farm transmission, resulting in high intra-host and inter-farm diversity [8, 21].

The high degree of nucleotide and amino acid variability, especially in regions linked to virulence and host immune response, speaks to the virus’s evolutionary adaptability. This genetic plasticity allows AMDV to persist and thrive in both densely populated mink farms and in dispersed wildlife populations. Phylogenetic trees based on complete genome sequences yield better-resolved transmission pathways compared to traditional partial gene sequencing approaches. Enhanced resolution has been critical in mapping specific transmission clusters and identifying patterns of inter-country viral movements [8]. Moreover, global phylodynamic studies suggest that viral passages among different geographic and host environments are major drivers of the observed nucleotide diversity, further complicating epidemiological tracking on a global scale [19].

Recombination, Host Jumps, and Evolutionary Dynamics

One of the key features of AMDV’s evolutionary strategy is the frequent occurrence of recombination events. When multiple strains co-infect a host, be it a farmed mink or a wild mustelid, the opportunity for genetic exchange increases, contributing to the emergence of new viral variants. Instances of recombination have been particularly noted in environments where intensive farming creates conditions for high-density housing and viral persistence [8, 21]. The genetic mosaicism observed in many viral genomes indicates that recombination is a recurrent mechanism that intertwines independent introduction events with local viral evolution.

This interplay of recombination and point mutations under the selective pressure of the host immune response also shapes the epidemiologic landscape of AMDV. The evolution of specific variants can often be linked to changes in clinical manifestation or disease severity. Although immune complex-mediated pathogenesis and hypergammaglobulinemia remain the hallmarks of disease, the molecular drivers of these properties have been linked to alterations in structural proteins such as VP2, which also serve as markers for phylogenetic diversification [1, 20]. Selective pressures are further amplified in scenarios of cross-species transmission as the virus adapts to different host immune environments. Studies have documented that species more closely related phylogenetically to mink tend to exhibit higher seroprevalence, a trend that suggests potential barriers to transmission imposed by host genetics and immune system variability [14].

Epidemiological Implications in Intensive Farming and Wildlife Reservoirs

Intensive farming practices create an ideal setting for the rapid spread and evolution of AMDV. High stocking densities, frequent animal movement, and insufficient biosecurity measures facilitate both horizontal and vertical transmission within farms. Molecular epidemiological tracking using partial NS1 gene sequences has proven invaluable in identifying outbreak clusters and linking them to specific transmission events on farms. Yet, evidence also points to the complexity added by the spillover of the virus into wild populations. For example, phylogenetic analyses in free-ranging mink have shown that strains circulating in the wild often exhibit distinct cluster patterns from those in farms, suggesting separate evolutionary trajectories despite some genetic overlap likely resulting from farm escapees or environmental contamination [3, 18].

From a global perspective underscored by authoritative bodies like the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH), understanding the epidemiology of economically critical pathogens such as AMDV is essential. Enhanced surveillance, incorporating both molecular diagnostics and serological monitoring, is crucial for mitigating the spread of the virus, limiting economic losses, and protecting both animal and public health [19]. These agencies advocate for integrated approaches that combine genetic data with classical epidemiological measures to formulate effective disease control strategies.

Insights from Phylogenetic Profiling and Future Directions

Advanced phylogenetic methodologies, including whole-genome sequencing and time-calibrated molecular clock models, are rapidly refining our understanding of AMDV’s evolutionary chronology. Isolates from various geographic regions reveal that some clades are region-specific, while others indicate viral exchange over long distances. Such findings are instrumental in the design of control programs and in refining breeding strategies for tolerance. The implementation of genomic selection in mink populations, which can integrate host SNP data with viral phylogenetic insights, presents a promising avenue to reduce the clinical burden of AMDV while also curbing its evolutionary potential.

In summary, the epidemiological profile and phylogenetic diversity of AMDV are shaped by a complex interplay of host factors, intensive farming practices, and viral evolutionary mechanisms such as recombination. These dynamics highlight the necessity for continuous monitoring and advanced molecular surveillance to effectively mitigate the impact of this pathogen in both captive and wild animal populations while addressing its broader implications for animal health on an international scale [1, 3, 8, 14, 18-21].

Diagnostics and Serological Testing Strategies for AMDV Detection

Detection of Aleutian mink disease virus (AMDV) has been a critical component in managing outbreaks and mitigating economic losses in both farmed and free-ranging mink populations. Given its persistence, high genetic heterogeneity, and complex infection dynamics, a multi-pronged diagnostic approach is essential. Both molecular assays and serological testing provide complementary data that allow for accurate detection, outbreak tracking, and disease management in keeping with guidelines from international authorities such as the CDC, WHO, and WOAH.

Molecular Diagnosis and PCR-Based Methodologies

Molecular approaches for AMDV detection have evolved significantly over the past years, providing enhanced sensitivity and specificity compared to traditional diagnostic techniques. Polymerase chain reaction (PCR) protocols have been optimized both for rapid field diagnostics and for detailed epidemiological surveillance. A notable advancement has been the development of real-time PCR assays based on probe-based and EvaGreen chemistries. For instance, a probe-based real-time PCR assay targeting the NS1 gene demonstrates high sensitivity with a detection limit of approximately 20 copies per reaction. This assay has been benchmarked against other available techniques and has shown both superior specificity and a rapid turnaround time, which is critical for timely decision-making in outbreak situations [23].

Similarly, an EvaGreen-based real-time PCR assay has been developed to detect AMDV in blood and tissue samples. This assay, designed on a nonstructural protein gene, is particularly notable for its universal detection capability, it identifies AMDV strains from distinct geographic regions (Chinese and American isolates) and achieves low detection limits (down to 1 copy/µL of AMDV plasmid) while showing robust reproducibility as reflected by low intra- and inter-assay variation coefficients [24]. These PCR strategies facilitate not only the confirmation of infection but also provide data that can be used to monitor viral load dynamics in both acute and chronic infections.

In addition to these real-time methodologies, direct detection methods using advanced polymerases such as Omni Klentaq-LA have enabled PCR amplification without a prior nucleic acid extraction step. This approach has proven especially useful in samples with low viral titers, such as chronically infected mink, where even minor losses during extraction could compromise detection [26]. Furthermore, whole-genome sequencing protocols that utilize long-range PCR amplification have been established allowing for comprehensive genetic characterization. This facilitates epidemiological tracking of viral strains, the elucidation of inter-farm transmission routes, and the measurement of evolutionary dynamics, all of which are essential to inform biosecurity guidelines as promoted by WOAH and the CDC [8, 13].

Serological Testing: From CIEP to Automated ELISA Platforms

Serological testing remains a cornerstone for the diagnosis of AMDV infection and plays a pivotal role in herd surveillance and selection programs. Historically, counter-immunoelectrophoresis (CIEP) has served as the gold standard for detecting AMDV-specific antibodies. CIEP offers a direct measure of the immune response and is associated with high sensitivity for detecting animals that have mounted an antibody response. However, the labor-intensive nature of CIEP and its comparatively slow throughput have driven the development of more automated and high-throughput serological assays.

Recent advances have seen the validation of several enzyme-linked immunosorbent assays (ELISAs), many of which utilize recombinant viral proteins as antigen targets. The use of VP2-based recombinant antigens, for example, has resulted in ELISA systems with very high sensitivity (up to 99.7%) and specificity (around 98.3%) when compared with CIEP [25, 28]. The automated ELISA system that incorporates sample collection via filter paper strips (often referred to as “blood comb” technology) has further improved the practicality of large-scale screening. With overall performance indicators such as a kappa value close to 0.976 and an agreement proportion of nearly 99%, these systems are now being adopted in eradication programs, providing rapid and reliable results that allow for quick intervention [25].

The molecular basis for improved performance in these serological tests lies in the antigenic composition used for coating ELISA plates. Studies have revealed that antigen sources greatly influence the assay's accuracy. While assays based on the AMDV-G strain as the antigen have occasionally suffered from lower sensitivity, switching to antigens derived from the VP2 protein, which more accurately represent immuno-dominant epitopes, has yielded significant improvements in diagnostic performance [28]. Notably, the quantification of antibody titers using these systems provides valuable prognostic information, particularly since high antibody titers in infected mink often correlate with disease severity and viral replication dynamics. This diagnostic insight is crucial for selective breeding programs aimed at increasing tolerance to AMDV infection, a strategy increasingly endorsed by both national and international animal health organizations.

Integrative Diagnostic Strategies and Future Perspectives

An effective diagnostic approach for AMDV integrates both molecular detection and serological assays. While PCR-based methods allow for the rapid identification of active infection through detection of viral DNA, serological assays reflect the long-term exposure history and the host’s immune response. The combination of these techniques enables the stratification of animals based on their infection status, whether they are actively viremic, in the process of seroconversion, or have persistent antibody responses indicative of chronic infection [23, 26, 27].

The application of multiplex testing strategies, such as TaqMan-based duplex assays, can simultaneously evaluate co-infections (for example, when screening for both AMDV and other pathogens such as Mink circovirus) and has proven essential to understand the epidemiological landscape in mink farms and surrounding wildlife reservoirs [11]. Moreover, emerging diagnostic modalities, including aptamer-based assays, are under investigation for their potential to inhibit virus replication and may provide synergistic diagnostic and therapeutic benefits in future applications [22].

The use of these sophisticated diagnostic tools is not only pivotal for controlling the spread of AMDV in farmed mink but also has broader implications for wildlife management and zoonotic risk mitigation. As AMDV continues to influence multiple species beyond the farm environment, adherence to internationally recognized guidelines from institutions like the CDC, WHO, and WOAH underscores the importance of rigorous diagnostics in maintaining public and animal health. This integration of molecular and serological testing methodologies therefore represents a critical pillar in both the immediate response to outbreaks and the long-term surveillance efforts necessary to combat this economically significant pathogen.

Impact on Mink Farming and Wildlife: Biosecurity and Disease Management

The introduction and persistence of Aleutian mink disease virus (AMDV) have had profound effects on mink farming, with repercussions extending to wildlife populations. The high genetic heterogeneity of AMDV strains in both farmed and free-ranging populations has complicated biosecurity strategies and disease management, directly affecting the economic stability of mink farms and the health of surrounding ecosystems [1, 20, 21]. As AMDV exhibits robust environmental stability and cross-species infection capabilities, recent studies emphasize the multifaceted challenges in containing viral spread along the farm–wild interface.

Economic and Operational Impacts on Mink Farming

Mink farming is exceedingly vulnerable to the pernicious effects of AMDV. Outbreaks of AMDV can trigger high mortality rates, reduce reproductive parameters, and lead to declines in pelt quality, all of which severely undermine productivity and profitability [34]. Experimental investigations have revealed that persistent viral infection can impair reproductive performance and even subtly reduce key biological indices such as litter size and neonatal survival [34]. Moreover, economic losses are amplified by the difficulty in eradicating the virus from a farm once it has become endemic. Often, AMDV’s presence is maintained through within-farm reservoirs that are sustained even after rigorous control measures, necessitating continual surveillance and adaptation of biosecurity protocols [20].

Daily management practices on mink farms must therefore incorporate stringent biosecurity measures, including controlled access to exotic species from the wild as well as visitor management using personal protective equipment (PPE). Environmental contamination with AMDV, documented both through direct animal testing and indirect sampling of the farm environment [6], underscores the critical necessity for routine disinfection protocols, strict quarantine procedures, and the implementation of robust surveillance programs. Agencies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) routinely advocate for integrated biosecurity practices for economically critical pathogens, a mandate that is highly relevant to controlling AMDV spread on mink farms.

Wildlife as Endemic Reservoirs and Spillover Risks

Parallel to the challenges experienced in mink farms, AMDV presents significant epidemiological risks to wild mustelid populations and other susceptible wildlife species. Studies conducted in free-ranging American mink populations have demonstrated high seroprevalence and persistent infection rates in wild mink and other mustelids, indicating that these animals are not only victims of AMDV but may also act as reservoirs for the virus [3, 18, 29]. This reservoir potential results in a bidirectional exchange of the virus between the farmed and wild populations. For example, genomic investigations in Poland have shown that viral strains isolated from free-ranging mink share high genetic similarity with those found on farms, suggesting frequent transmission events that challenge localized control efforts [3, 18].

In addition, interspecies transmission has been documented among native mustelids, where species more phylogenetically related to mink displayed significantly elevated seroprevalence levels [14]. Wildlife species often exhibit subclinical infections, making them difficult to identify as carriers, yet they steadily contribute to environmental contamination through fecal shedding and other secretions [1, 3]. Field studies have also noted the role of alternative vectors, such as the lesser housefly, which may mechanically spread AMDV across the farm environment, further complicating containment strategies [32]. The persistent circulation of viral strains in the wild calls for comprehensive, ecosystem-wide approaches that are coordinated through a One Health perspective, incorporating recommendations from the Centers for Disease Control and Prevention (CDC) on zoonotic and economically impactful viruses.

Biosecurity Measures and Diagnostic Strategies

A thorough evaluation of biosecurity protocols is pivotal for effective disease management. Recent investigations have highlighted the importance of high-throughput diagnostics and reliable serological assays in mitigating viral spread. Automated ELISA systems, which have exhibited high sensitivity and specificity for AMDV antibody detection, provide many advantages over traditional testing methods such as counter-immunoelectrophoresis (CIEP) in large-scale screening operations [25, 28]. Rapid on-site diagnostic tools, including real-time PCR assays, have improved the ability to detect low-level viremia in chronically infected mink, enabling early intervention and reinforcing farm biosecurity [23, 24, 26]. Such tools, validated by public health and veterinary organizations like WOAH, are indispensable in both outbreak tracking and routine surveillance.

Furthermore, studies focusing on molecular markers and selection signatures for host tolerance have provided promising insights into breeding strategies aimed at reducing the adverse effects of AMDV infection [17, 30, 31]. Breed improvement through selection for traits associated with reduced viral replication and lower antibody titers has the potential significantly to diminish virus circulation and mitigate clinical manifestations in farmed mink. However, it remains critical that such genetic approaches be coupled with rigorous environmental and vector control measures since the surrounding wildlife continues to serve as a continuous source of AMDV spillover [1, 3, 21].

The application of strict disinfection procedures, combined with the mandatory use of certified PPE and worker training, has been demonstrated to reduce bio-contamination risks significantly [33]. These methods are complemented by advanced epidemiological tracking tools based on whole-genome sequencing, which offer enhanced resolution for mapping transmission pathways across farms and adjacent wild habitats [8]. For economically critical pathogens like AMDV, integrating such advanced molecular epidemiology methods with comprehensive on-farm and ecosystem biosecurity strategies is essential, as recommended by international agencies including the CDC and FAO.

Integration of Farm Management with Wildlife Health

Ultimately, the impact of AMDV on mink farming cannot be separated from the broader implications for wildlife health and ecosystem stability. The persistent interaction between domestic animals and wild reservoirs necessitates a unified approach in disease management that is built upon coordinated surveillance, stringent biosecurity measures, and robust diagnostic technologies [3, 18]. As mink farms strive to adopt genetic selection approaches for enhanced disease tolerance, they must equally incorporate strategic measures directed at minimizing cross-species transmission. The ongoing challenges posed by AMDV demand a vigilant, multidisciplinary effort that unites veterinary science, molecular epidemiology, and public health practices to safeguard animal welfare, protect agricultural economic interests, and prevent spillover events into wild populations.

Future Directions in Research and Control Strategies for Aleutian Mink Disease Virus

In light of the extensive research carried out over recent decades, the future of Aleutian mink disease virus (AMDV) control and remediation hinges on a multifaceted strategy integrating molecular epidemiology, advanced immunogenetics, novel antiviral therapeutics, and rigorous biosecurity measures. As AMDV continues to significantly impact mink farming worldwide, with repercussions for wildlife and, potentially, zoonotic spillover scenarios appreciated by entities such as the World Organisation for Animal Health (WOAH) and the Centers for Disease Control and Prevention (CDC), future research must elucidate the virus’s underlying biology and transmission pathways to design targeted interventions [1, 4, 19].

Advancing Molecular and Genomic Studies

The high genetic heterogeneity of AMDV, as evidenced in numerous studies using partial and full-genome sequencing [1, 8, 12, 13], points to an evolutionary arms race that demands continual genomic surveillance. Future research directions should focus on whole-genome sequencing to capture the full breadth of genetic diversity and recombination events that define AMDV populations. This approach will allow researchers to trace viral lineage, understand inter-farm transmission dynamics [8, 38], and reveal genomic regions under selective pressure, thus illuminating candidate targets for therapeutic intervention. Phylodynamic analyses, enhanced by molecular clock models, can be utilized to chronicle the virus’s evolutionary history and spread dynamics across different geographic locations and species, a line of inquiry which is critical considering evidence of multiple introductions and the formation of endemic clusters [1, 8, 19].

Furthermore, mining host-virus interaction data through advanced transcriptomic profiling, such as the elucidation of immune response genes in infected mink spleens [15], provides an opportunity to identify biomarkers for early disease detection. In addition, leveraging genome-wide association studies (GWAS) to discern signatures of selection for viral tolerance [30, 31] has the potential to revolutionize breeding strategies, favoring the propagation of mink populations with inherent resistance. Investments in high-throughput molecular diagnostic tools, based on innovative real-time PCR assays [23, 24, 26], offer promising prospects for rapid and sensitive detection of AMDV, facilitating on-farm decision-making and international trade compliance as recommended by CDC and WOAH guidelines.

Immunogenetics, Vaccine Research, and Novel Therapeutics

Given the persistence of AMDV in both farmed and free-ranging mink populations, genetic selection for disease tolerance is emerging as a cornerstone in future control efforts. Research examining polymorphisms in genes such as RNF165 [16] offers insights into innate resistance mechanisms that may be harnessed in selective breeding programs. The subsequent integration of marker-assisted selection into breeding operations can potentially yield mink cohorts capable of sustaining lower viral replication, reduced immune complex formation, and milder clinical outcomes [17, 35]. In parallel, elucidating the molecular function of viral nonstructural proteins (NS2 and NS3) and their role in virus replication [5] may uncover novel targets for antiviral drug development.

Despite the long-standing challenges of developing an effective vaccine for AMDV, recent advances in structural virology [2] open the door to rational vaccine design. High-resolution capsid structures not only provide a framework for understanding viral entry and immune evasion but also can inform the engineering of vaccine candidates that mimic native antigenic conformations. Concurrently, the promise shown by aptamer-based therapeutics warrants further exploration, as demonstrated by the inhibition of viral replication in vitro [22]. Aptamers, with their high specificity and relatively prolonged half-life, could serve as potent adjuncts or standalone treatments, especially when integrated with improved delivery systems.

Integrative Approaches to Biosecurity and Disease Control

Controlling AMDV will require an integrated One Health perspective that bridges the gap between wildlife reservoirs and intensive farming operations [3, 18]. Future research should prioritize studies that assess virus transmission at the wild–domestic interface, with attention to spillover events involving invasive species such as feral mink and native mustelids [14, 18]. Investigations into environmental vectors, including the role of flies as potential mechanical transmitters [32] and the contamination levels on visitors’ personal protective equipment [33], highlight the importance of robust farm biosecurity protocols. On-farm management can benefit from the application of validated automated serological assays [25, 28] and enhanced PCR-based detection methodologies which are crucial for real-time monitoring of herd status.

Biosecurity measures should be reinforced by a combination of rapid diagnostic tools and enhanced farm management practices. Coupled with the development of novel antiviral agents and the strategic improvement of nutritional supplements, such as kelp supplementation shown to ameliorate kidney dysfunction in infected mink [36, 37], these multifactorial approaches have the potential to reduce viral load and minimize clinical impact even in the absence of complete virus eradication. Such integrative strategies, aligned with guidelines from international bodies like the Food and Agriculture Organization (FAO) and WOAH, provide a balanced roadmap that targets both viral control and animal welfare improvement.

Finally, the establishment of global databases that compile genomic, epidemiological, and serological data will provide a centralized resource for tracking AMDV evolution and spread. These initiatives, integrated with collaborative research networks, will be paramount in guiding future policy formulations and in designing cost-effective intervention strategies. Enhanced funding for multidisciplinary research projects that cover everything from fundamental virology to applied breeding strategies is essential for creating a sustainable control framework for AMDV.

References

[1] Tong M, Sun N, Cao Z, Cheng Y, Zhang M, Cheng S, et al.. Molecular epidemiology of Aleutian mink disease virus from fecal swab of mink in northeast China. BMC Microbiology. 2020. DOI: https://doi.org/10.1186/s12866-020-01910-8

[2] Lakshmanan R, Mietzsch M, Ybargollin AJ, Chipman P, Fu X, Qiu J, et al.. Capsid Structure of Aleutian Mink Disease Virus and Human Parvovirus 4: New Faces in the Parvovirus Family Portrait. Viruses. 2022. DOI: https://doi.org/10.3390/v14102219

[3] Przywara K, Siemionek J, Jakubowski T, Kończyk-Kmiecik K, Szczerba-Turek A. Prevalence of Aleutian Mink Disease Virus (AMDV) in Free-Ranging American Mink from Biebrza and Narew National Parks (Poland), An Epidemiological Concern. Animals. 2024. DOI: https://doi.org/10.3390/ani14172584

[4] Vahedi SM, Ardestani SS, Banabazi MH, Clark FK. Epidemiology, pathogenesis, and diagnosis of Aleutian disease caused by Aleutian mink disease virus: A literature review with a perspective of genomic breeding for disease control in American mink (Neogale vison). Virus Research. 2023. DOI: https://doi.org/10.1016/j.virusres.2023.199208

[5] Huang Q, Luo Y, Cheng F, Best S, Bloom M, Qiu J. Molecular Characterization of the Small Nonstructural Proteins of Parvovirus Aleutian Mink Disease Virus (AMDV) During Infection. Virology. 2014. DOI: https://doi.org/10.1016/j.virol.2014.01.005

[6] Kowalczyk M, Horecka B, Jakubczak A. Aleutian Mink Disease Virus in the breeding environment in Poland and its place in the global epidemiology of AMDV.. Virus Research. 2019. DOI: https://doi.org/10.1016/j.virusres.2019.197665

[7] Jepsen J, D’Amore F, Baandrup U, Clausen M, Gottschalck E, Aasted B. Aleutian Mink Disease Virus and Humans. Emerging Infectious Diseases. 2009. DOI: https://doi.org/10.3201/eid1512.090514

[8] Hagberg E, Pedersen A, Larsen L, Krarup A. Evolutionary analysis of whole-genome sequences confirms inter-farm transmission of Aleutian mink disease virus.. Journal of General Virology. 2017. DOI: https://doi.org/10.1099/jgv.0.000777

[9] Canuti M, O'Leary K, Hunter B, Spearman G, Ojkić D, Whitney H, et al.. Driving forces behind the evolution of the Aleutian mink disease parvovirus in the context of intensive farming. Virus Evolution. 2016. DOI: https://doi.org/10.1093/ve/vew004

[10] Jensen TH, Uttenthal A. Aleutian mink disease virus. CABI Compendium. 2016. DOI: https://doi.org/10.1201/B19719-80

[11] Leng X, Sheng C, Wang T, Liang J, Song Y, Wang X, et al.. Detection of co-infection and phylogenetic analysis of Mink circovirus and Aleutian mink disease virus in minks, foxes and raccoon dogs in northern China. Veterinarski arhiv (Tisak). 2025. DOI: https://doi.org/10.24099/vet.arhiv.2711

[12] Cui X, Yang Y, Wang F, Luo J, Zhang P, Chen H, et al.. Genomic characterization and phylogenetic analysis of Aleutian mink disease virus identified in a sudden death mink case.. Comparative Immunology, Microbiology & Infectious Diseases. 2023. DOI: https://doi.org/10.1016/j.cimid.2023.102052

[13] Hagberg E, Krarup A, Fahnøe U, Larsen L, Dam-Tuxen R, Pedersen A. A fast and robust method for whole genome sequencing of the Aleutian Mink Disease Virus (AMDV) genome.. Journal of Virological Methods. 2016. DOI: https://doi.org/10.1016/j.jviromet.2016.03.010

[14] Zalewski A, Kołodziej-Sobocińska M, Virtanen J, Zalewska H, Sironen T, Zub K, et al.. Drivers Shaping Spillover of Aleutian Mink Disease Virus Introduced With American Mink Among Native Mustelids. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/3184679

[15] Bishop D, Farid A, Do D, Miar Y. Transcriptomic profiling of mink spleen infected by Aleutian mink disease virus: Insight into immune response.. Research in Veterinary Science. 2025. DOI: https://doi.org/10.1016/j.rvsc.2025.105842

[16] Mazurkiewicz I, Jakubczak A, Kowalczyk M. Polymorphism of the RNF165 Gene in American Mink (Neogale vison) as a Potential Factor Responsible for Resistance to Infection with the Aleutian Mink Disease Virus. Genes. 2025. DOI: https://doi.org/10.3390/genes16121417

[17] Farid A, Hussain I, Rupasinghe P, Stephen J, Arju I. Long-term antibody production and viremia in American mink (Neovison vison) challenged with Aleutian mink disease virus. BMC Veterinary Research. 2022. DOI: https://doi.org/10.1186/s12917-022-03462-7

[18] Virtanen J, Zalewski A, Kołodziej-Sobocińska M, Brzeziński M, Smura T, Sironen T. Diversity and transmission of Aleutian mink disease virus in feral and farmed American mink and native mustelids. Virus Evolution. 2021. DOI: https://doi.org/10.1093/ve/veab075

[19] Franzo G, Legnardi M, Grassi L, Dotto G, Drigo M, Cecchinato M, et al.. Impact of viral features, host jumps and phylogeography on the rapid evolution of Aleutian mink disease virus (AMDV). Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-96025-z

[20] Prieto A, Fernández-Antonio R, López-Lorenzo G, Díaz-Cao JM, López-Novo C, Remesar S, et al.. Molecular epidemiology of Aleutian mink disease virus causing outbreaks in mink farms from Southwestern Europe: a retrospective study from 2012 to 2019. Journal of Veterinary Sciences. 2020. DOI: https://doi.org/10.4142/jvs.2020.21.e65

[21] Virtanen J, Smura T, Aaltonen K, Moisander-Jylhä A, Knuuttila A, Vapalahti O, et al.. Co-circulation of highly diverse Aleutian mink disease virus strains in Finland.. Journal of General Virology. 2019. DOI: https://doi.org/10.1099/jgv.0.001187

[22] Lu T, Zhang H, Zhou J, Ma Q, Yan W, Zhao L, et al.. Aptamer-targeting of Aleutian mink disease virus (AMDV) can be an effective strategy to inhibit virus replication. Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-84223-8

[23] Virtanen J, Aaltonen K, Vapalahti O, Sironen T. Development and validation of nucleic acid tests to diagnose Aleutian mink disease virus.. Journal of Virological Methods. 2019. DOI: https://doi.org/10.1016/j.jviromet.2019.113776

[24] Li L, Hu Z, Sun J, Guo K, Chu X, Wang X, et al.. Development of an EvaGreen-based real-time PCR assay for detection of Aleutian mink disease virus.. Journal of Virological Methods. 2019. DOI: https://doi.org/10.1016/j.jviromet.2019.113751

[25] Knuuttila A, Aronen P, Eerola M, Gardner I, Virtala A, Vapalahti O. Validation of an automated ELISA system for detection of antibodies to Aleutian mink disease virus using blood samples collected in filter paper strips. Virology Journal. 2014. DOI: https://doi.org/10.1186/1743-422X-11-141

[26] Farid A, Rupasinghe P. A fast and accurate method of detecting Aleutian mink disease virus in blood and tissues of chronically infected mink.. Canadian Journal of Microbiology (print). 2017. DOI: https://doi.org/10.1139/cjm-2016-0567

[27] Farid A, Rupasinghe P. Accuracy of enzyme-linked immunosorbent assays for quantification of antibodies against Aleutian mink disease virus.. Journal of Virological Methods. 2016. DOI: https://doi.org/10.1016/j.jviromet.2016.06.004

[28] Andersson A, Wallgren P. Evaluation of two enzyme-linked immunosorbent assays for serodiagnosis of Aleutian mink disease virus infection in mink. Acta Veterinaria Scandinavica. 2013. DOI: https://doi.org/10.1186/1751-0147-55-86

[29] Martino P, Samartino L, Stanchi N, Radman N, Parrado E. Serology and protein electrophoresis for evidence of exposure to 12 mink pathogens in free-ranging American mink (Neovison vison) in Argentina. Veterinary Quarterly. 2017. DOI: https://doi.org/10.1080/01652176.2017.1336810

[30] Karimi K, Farid A, Myles S, Miar Y. Detection of selection signatures for response to Aleutian mink disease virus infection in American mink. Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-82522-8

[31] Karimi K, Farid A, Myles S, Miar Y. PSXII-24 Identification of selection signatures for response of American mink to Aleutian mink disease virus infection. Journal of Animal Science. 2020. DOI: https://doi.org/10.1093/jas/skaa278.443

[32] Prieto A, Díaz-Cao JM, Fernández-Antonio R, Panadero R, López-Lorenzo G, Díaz P, et al.. Lesser housefly (Fannia canicularis) as possible mechanical vector for Aleutian mink disease virus.. Veterinary Microbiology. 2018. DOI: https://doi.org/10.1016/j.vetmic.2018.05.024

[33] Cao JMD, Prieto A, López G, Fernández-Antonio R, Díaz P, López C, et al.. Molecular assessment of visitor personal protective equipment contamination with the Aleutian mink disease virus and porcine circovirus-2 in mink and porcine farms. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0203144

[34] Reichert M, Kostro K. Effect of Persistent Infection of Mink with Aleutian Mink Disease Virus on Reproductive Failure. Bulletin of the Veterinary Institute in Pulawy. 2014. DOI: https://doi.org/10.2478/BVIP-2014-0057

[35] Virtanen J, Aaltonen K, Moisander-Jylhä A, Nordgren H, Paulin L, Peura J, et al.. Mechanisms behind the varying severity of Aleutian mink disease virus: Comparison of three farms with a different disease status.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.21203/rs.3.rs-1283464/v1

[36] Farid A, Smith NJ. Dietary supplementation of Ascophylum nodosum improved kidney function of mink challenged with Aleutian mink disease virus. BMC Veterinary Research. 2020. DOI: https://doi.org/10.1186/s12917-020-02685-w

[37] Farid A, Smith NJ, White M. Effects of dietary kelp (Ascophylum nodosum) supplementation on survival rate and reproductive performance of mink challenged with Aleutian mink disease virus. Canadian Journal of Animal Science. 2020. DOI: https://doi.org/10.1139/cjas-2019-0221

[38] Ryt-Hansen P, Hjulsager C, Hagberg E, Chriel M, Struve T, Pedersen AG, et al.. Outbreak tracking of Aleutian mink disease virus (AMDV) using partial NS1 gene sequencing. Virology Journal. 2017. DOI: https://doi.org/10.1186/s12985-017-0786-5